Ervebo solution for injection Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP clinical trials

Durability of Immunity induced by the Ebolavirus Vaccine VSV-EBOV and Assessment of a Booster Dose for Pre-Exposure Prophylaxis in Individuals at Potential Occupational Risk for Ebolavirus Exposure: a German Multicenter Study (PREPARE-Germany)

This study looks at how long protection from the Ebola vaccine (Ervebo) lasts in people who might be exposed to the virus at work. It also checks if a booster shot helps. Researchers will follow adults in Germany for two years.